Seung Min Kim

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

James F. Howard, Kimiaki Utsugisawa, Michael Benatar et al. · The Lancet Neurology · 2017 · 800 citations

Medicine, Pharmacology, Pharmacotherapy +6

Different clinical and magnetic resonance imaging features between Charcot–Marie–Tooth disease type 1A and 2A

Ki Wha Chung, Bum Chun Suh, Michael E. Shy et al. · Neuromuscular Disorders · 2008 · 101 citations · Full text

Medicine, Oral Radiology, Diagnostic Imaging +3

Sequential combination of intravenous recombinant tissue plasminogen activator and intra-arterial urokinase in acute ischemic stroke.

Kyung‐Yul Lee, Seo Hyun Kim, Seung Ik Lee et al. · PubMed · 2004 · 85 citations · Full text

Pharmacy, Pharmacotherapy, Cardiovascular Pharmacotherapy +16

Post-intervention Status in Patients With Refractory Myasthenia Gravis Treated With Eculizumab During REGAIN and Its Open-Label Extension

Renato Mantegazza, Gil I. Wolfe, Srikanth Muppidi et al. · Neurology · 2020 · 79 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +9

Comparison of the characteristics for in‐hospital and out‐of‐hospital ischaemic strokes

H. J. Park, H. J. Cho, Young Dae Kim et al. · European Journal of Neurology · 2009 · 74 citations · Full text

Medicine, Cardiology, Surgery +11